Louisiana GOP shelves measure targeting adult trans healthcare

Louisiana lawmakers have unexpectedly stalled a resolution that could have laid the groundwork for new restrictions on gender-affirming care for trans adults, particularly those under 26.

According to a report by Transitics, Republicans on a key House committee voted unanimously to defer House Resolution 290, a proposal from Rep. Jessica Domangue, a self-described moderate Republican with no prior record of sponsoring anti-trans legislation. With the legislative session scheduled to end on June 1, the move effectively sidelines the resolution for the rest of the year.

HR 290 directed the Louisiana Department of Health (LDH) to “study the potential correlation” between medications used in gender-affirming hormone therapy and “psychosis and related psychiatric conditions” in people aged 26 and under. The text ordered a review of medical literature, adverse event data and consultations with a broad range of clinicians, culminating in recommendations on informed consent standards, screening, mental health evaluations and monitoring protocols.

LGBTQ+ advocates and medical experts have repeatedly warned that such “studies” are often designed to justify restrictions on access to care, not to neutrally evaluate evidence. The resolution’s language closely tracks talking points used by national anti-trans campaigns, which falsely suggest that hormone therapy causes severe psychiatric illness in trans people and use those claims to rationalize bans on adult care.

The proposal also arrived in a state where the political and administrative posture is already hostile to trans healthcare. Since 2023, Louisiana has prohibited gender-affirming medical treatment for minors, ignoring sustained opposition from major medical associations. In 2024, under Republican Governor Jeff Landry, LDH quietly removed Medicaid coverage for gender-affirming care, despite an existing 2022 policy that identifies such care as medically necessary.

Critics argued that directing LDH to study psychosis, schizophrenia-spectrum disorders, extreme mood disturbances, dissociative conditions and suicidal ideation in connection with hormone therapy would invite biased interpretation and selective use of data. They noted that a recent federal “review” commissioned under Donald Trump and conducted by outspoken opponents of gender-affirming care was subsequently used to rationalize nationwide policy rollbacks and Executive Order 14187’s restrictions on care for young people.

In committee, Domangue framed her effort as a neutral exercise, saying she “would like to see the data” and largely restricting her public comments to adolescent care. The resolution’s explicit inclusion of adults up to age 26, however, raised alarm that the study would be used to recommend tighter gatekeeping or even new legal barriers for trans adults.

Opposition came from an unexpected figure: Republican Rep. Rhonda Butler. Butler objected that the study could reopen debate over Louisiana’s existing ban on care for minors, expressing concern that a serious review might support the medical consensus in favor of gender-affirming treatment and provide ammunition to those seeking to roll back current restrictions.

Butler cited Utah as a cautionary example. After Utah legislators ordered a similar review of outcomes following a ban on care for trans youth, the resulting data supported the benefits of gender-affirming treatment and became a central argument against the state’s restrictions.

Butler also questioned the practicality of Domangue’s proposal, noting that LDH would struggle to gather Louisiana-based outcome data while essential treatments remain illegal for minors in the state. She warned that the study could encounter “big roadblocks” and moved to defer the resolution.

Faced with that resistance, Domangue chose to voluntarily defer HR 290 rather than push for a vote. The exchange suggested that she may revisit the concept with revised language in a future session.

For trans adults and young people in Louisiana and beyond, the deferral is a concrete, if temporary, relief. While HR 290 did not itself impose new restrictions, its structure signaled an intent to produce a state-sanctioned narrative that could be used to erode informed consent models and justify new legal barriers, both within Louisiana and in other conservative states watching closely for precedents.

The current pause does not resolve ongoing threats to gender-affirming care, particularly in states where political actors are actively searching for pseudo-scientific justification to limit or deny treatment to trans adults. Yet it demonstrates that even within Republican caucuses, there can be skepticism toward measures that risk exposing the weakness of existing bans when confronted with real-world data and lived experience.

At a time when LGBTQ+ communities are under sustained legislative pressure, building economic and professional security remains crucial. Platforms like myGwork help LGBTQ+ professionals and allies connect with inclusive employers and supportive networks. For those who care about protecting trans rights and affirming workplaces, signing up for myGwork is one way to strengthen community resilience beyond the legislature.